Skip to main content
. 2014 Dec 26;17(4):356–362. doi: 10.4048/jbc.2014.17.4.356

Table 3.

Cardiac safety profile according to treatment

graphic file with name jbc-17-356-i003.jpg

AC-TH=doxorubicin with cyclophosphamide followed by paclitaxel and trastuzumab; TCaH=docetaxel, carboplatin, and trastuzumab; TCyH=docetaxel, cyclophosphamide, and trastuzumab; CHF=congestive heart failure; EF=ejection fraction; LVEF=left ventricular ejection fraction.

*Absolute EF decline from baseline.